ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARK COPPESS MD

Clinical Cardiac Electrophysiology

7,778

$406K

635
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $55

DAVID WENDT MD

Clinical Cardiac Electrophysiology

6,975

$620K

643
576 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 20%

$89
Average prescription price

Avg: $55

ERIC JOHNSON MD

Clinical Cardiac Electrophysiology

6,066

$385K

476
409 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 20%

$63
Average prescription price

Avg: $55

JAMES BAKER M.D.

Clinical Cardiac Electrophysiology

5,002

$273K

618
535 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

2%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $55

JEFFREY BAERMAN MD

Clinical Cardiac Electrophysiology

4,960

$215K

490
406 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $55

JOHN ARNETT M.D.

Clinical Cardiac Electrophysiology

4,601

$255K

710
604 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $55

GREGORY BRUCE M.D.

Clinical Cardiac Electrophysiology

4,490

$200K

624
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $55

DAVID SALERNO MD

Clinical Cardiac Electrophysiology

4,388

$201K

612
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $55

GREGG SHANDER MD

Clinical Cardiac Electrophysiology

3,859

$147K

533
465 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $55

WILLIAM WASSYNGER M.D.

Clinical Cardiac Electrophysiology

3,580

$197K

385
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $55

JAMES MERRILL MD

Clinical Cardiac Electrophysiology

3,207

$176K

388
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $55

ROBERT PICKETT M.D.

Clinical Cardiac Electrophysiology

2,937

$152K

404
350 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $55

JAMES COX M.D.

Clinical Cardiac Electrophysiology

2,693

$218K

323
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 20%

$81
Average prescription price

Avg: $55

CHRISTOPHER CONLEY M.D.

Clinical Cardiac Electrophysiology

2,593

$99.4K

287
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $55

MICHAEL ALLAN MD

Clinical Cardiac Electrophysiology

2,590

$129K

427
371 are 65+

13%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $55

JEFFREY HIRSH M.D.

Clinical Cardiac Electrophysiology

2,513

$158K

292
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 20%

$63
Average prescription price

Avg: $55

TIMOTHY TALBERT MD

Clinical Cardiac Electrophysiology

2,488

$115K

345
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $55

WILLIAM THOMPSON M.D.

Clinical Cardiac Electrophysiology

2,332

$105K

347
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $55

GREGORY BASHIAN M.D.

Clinical Cardiac Electrophysiology

2,282

$122K

311
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$54
Average prescription price

Avg: $55

ARUN RAO MD

Clinical Cardiac Electrophysiology

2,190

$119K

381
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 20%

$54
Average prescription price

Avg: $55

THOMAS WILLIAMS M.D.

Clinical Cardiac Electrophysiology

2,097

$63.2K

278
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 20%

$30
Average prescription price

Avg: $55

MARK WATHEN MD

Clinical Cardiac Electrophysiology

2,084

$98.4K

319
267 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 20%

$47
Average prescription price

Avg: $55

JAMES LITZOW M.D.

Clinical Cardiac Electrophysiology

2,028

$87.4K

338
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $55

JEFFREY KERLAN M.D.

Clinical Cardiac Electrophysiology

1,968

$92.4K

266
217 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$47
Average prescription price

Avg: $55

DAVID LAN MD

Clinical Cardiac Electrophysiology

1,925

$97.5K

277
223 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$51
Average prescription price

Avg: $55

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank